MediciNova (TSE:4875) Current Accrued Expense : 円222.9 Mil (As of Mar. 2024)

View and export this data going back to 2005. Start your Free Trial

What is MediciNova Current Accrued Expense?

MediciNova's Current Accrued Expense for the quarter that ended in Mar. 2024 was 円222.9 Mil.

MediciNova's quarterly Current Accrued Expense declined from Sep. 2023 (円274.8 Mil) to Dec. 2023 (円154.1 Mil) but then increased from Dec. 2023 (円154.1 Mil) to Mar. 2024 (円222.9 Mil).

MediciNova's annual Current Accrued Expense increased from Dec. 2021 (円126.8 Mil) to Dec. 2022 (円202.5 Mil) but then declined from Dec. 2022 (円202.5 Mil) to Dec. 2023 (円154.1 Mil).

MediciNova Current Accrued Expense Historical Data

The historical data trend for MediciNova's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MediciNova Current Accrued Expense Chart

MediciNova Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Current Accrued Expense

Get a 7-Day Free Trial

71.35

48.47

126.81

202.51

154.06

MediciNova Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Current Accrued Expense	Get a 7-Day Free Trial															265.72	292.89	274.84	154.06	222.93

MediciNova Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

MediciNova Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of MediciNova's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

MediciNova (TSE:4875) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MediciNova Inc (TSE:4875) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

MNOV:USA

Address

4275 Executive Square, Suite 300, La Jolla, CA, USA, 92037

Website

https://www.medicinova.com

MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.

MediciNova (TSE:4875) Headlines

No Headlines